|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 368.36 USD | +0.07% |
|
+2.12% | +12.73% |
| 01:12am | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
| 07:19pm | Morgan Stanley Adjusts Price Target Amgen to $333 From $340, Maintains Equalweight Rating | MT |
| Market Cap | 199B 174B 160B 149B 282B 18,855B 286B 1,921B 747B 9,305B 746B 730B 32,164B | P/E 2026 * |
24.1x | P/E 2027 * | 22.1x |
|---|---|---|---|---|---|
| Enterprise Value | 241B 211B 194B 180B 342B 22,848B 347B 2,328B 905B 11,276B 904B 884B 38,974B | EV / Sales 2026 * |
6.37x | EV / Sales 2027 * | 6.07x |
| Free-Float |
99.78% | Yield 2026 * |
2.74% | Yield 2027 * | 2.9% |
Last Transcript: Amgen Inc.
| 1 day | +0.06% | ||
| 1 week | +2.12% | ||
| Current month | +1.90% | ||
| 1 month | +6.73% | ||
| 3 months | +5.48% | ||
| 6 months | +11.78% | ||
| Current year | +12.73% |
| 1 week | 359.47 |  | 375.25 |
| 1 month | 334.05 | | 375.25 |
| Current year | 318.21 | | 391.29 |
| 1 year | 269.77 | | 391.29 |
| 3 years | 218.61 | | 391.29 |
| 5 years | 198.64 | | 391.29 |
| 10 years | 133.64 | | 391.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 01/05/2012 |
| Director of Finance/CFO | 62 | 13/05/2010 | |
Peter Griffith
DFI | Director of Finance/CFO | 67 | 01/01/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 63 | 01/01/2013 |
Tyler Jacks
BRD | Director/Board Member | 65 | 01/01/2012 |
Robert Eckert
BRD | Director/Board Member | 71 | 01/01/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/05 | Free | Director | 665 | 0.0001% | ||
| 19/05 | Free | Director | 665 | 0.0001% | ||
| 19/05 | Free | Director | 665 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.07% | +2.12% | +24.24% | +64.19% | 199B | |
| -0.22% | +3.04% | +57.90% | +170.97% | 1,102B | |
| -0.20% | +5.04% | +71.25% | +67.26% | 643B | |
| -0.25% | +1.19% | +33.88% | +88.91% | 450B | |
| -1.35% | +1.86% | +29.96% | +26.26% | 336B | |
| -0.71% | +0.72% | +28.85% | +46.77% | 288B | |
| -1.31% | -0.26% | -28.18% | -39.13% | 222B | |
| -0.66% | +7.62% | +22.07% | +79.12% | 169B | |
| +0.64% | +1.65% | -5.25% | -31.96% | 137B | |
| -2.26% | +2.70% | +9.67% | +48.49% | 133B | |
| Average | -0.65% | +2.55% | +24.44% | +52.09% | 367.77B | |
| Weighted average by Cap. | -0.50% | +2.19% | +39.73% | +85.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.78B 33.06B 30.47B 28.24B 53.61B 3,586B 54.48B 365B 142B 1,770B 142B 139B 6,117B | 38.73B 33.9B 31.24B 28.95B 54.96B 3,676B 55.85B 375B 146B 1,814B 145B 142B 6,271B |
| Net income | 8.23B 7.2B 6.64B 6.15B 11.68B 781B 11.87B 79.6B 30.96B 386B 30.9B 30.23B 1,333B | 8.86B 7.76B 7.15B 6.63B 12.58B 841B 12.78B 85.73B 33.34B 415B 33.28B 32.56B 1,435B |
| Net Debt | 42.07B 36.81B 33.93B 31.45B 59.7B 3,993B 60.66B 407B 158B 1,971B 158B 155B 6,811B | 36.52B 31.95B 29.45B 27.3B 51.82B 3,466B 52.65B 353B 137B 1,710B 137B 134B 5,912B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/07/26 | USD 368.39 | +0.08% | 593,111 |
| 07/07/26 | USD 368.10 | +0.45% | 1,983,666 |
| 06/07/26 | USD 366.44 | -2.06% | 2,838,007 |
| 02/07/26 | USD 374.15 | +3.55% | 2,487,837 |
| 01/07/26 | USD 361.33 | -0.22% | 2,244,791 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMGN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
